BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33610914)

  • 61. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
    Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
    J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152.
    Yao Y; Ma J; Xue Y; Wang P; Li Z; Liu J; Chen L; Xi Z; Teng H; Wang Z; Li Z; Liu Y
    Cancer Lett; 2015 Apr; 359(1):75-86. PubMed ID: 25578780
    [TBL] [Abstract][Full Text] [Related]  

  • 63. SH3BGRL2 inhibits growth and metastasis in clear cell renal cell carcinoma via activating hippo/TEAD1-Twist1 pathway.
    Yin L; Li W; Xu A; Shi H; Wang K; Yang H; Wang R; Peng B
    EBioMedicine; 2020 Jan; 51():102596. PubMed ID: 31911271
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Targeting the ABC transporter ABCB5 sensitizes glioblastoma to temozolomide-induced apoptosis through a cell-cycle checkpoint regulation mechanism.
    Lee CAA; Banerjee P; Wilson BJ; Wu S; Guo Q; Berg G; Karpova S; Mishra A; Lian JW; Tran J; Emmerich M; Murphy GF; Frank MH; Frank NY
    J Biol Chem; 2020 May; 295(22):7774-7788. PubMed ID: 32317280
    [TBL] [Abstract][Full Text] [Related]  

  • 65. HDAC6 inhibition induces glioma stem cells differentiation and enhances cellular radiation sensitivity through the SHH/Gli1 signaling pathway.
    Yang W; Liu Y; Gao R; Yu H; Sun T
    Cancer Lett; 2018 Feb; 415():164-176. PubMed ID: 29222038
    [TBL] [Abstract][Full Text] [Related]  

  • 66. miR‑378a‑3p inhibits cellular proliferation and migration in glioblastoma multiforme by targeting tetraspanin 17.
    Guo XB; Zhang XC; Chen P; Ma LM; Shen ZQ
    Oncol Rep; 2019 Nov; 42(5):1957-1971. PubMed ID: 31432186
    [TBL] [Abstract][Full Text] [Related]  

  • 67. VDAC2 interacts with PFKP to regulate glucose metabolism and phenotypic reprogramming of glioma stem cells.
    Zhou K; Yao YL; He ZC; Chen C; Zhang XN; Yang KD; Liu YQ; Liu Q; Fu WJ; Chen YP; Niu Q; Ma QH; Zhou R; Yao XH; Zhang X; Cui YH; Bian XW; Shi Y; Ping YF
    Cell Death Dis; 2018 Sep; 9(10):988. PubMed ID: 30250190
    [TBL] [Abstract][Full Text] [Related]  

  • 68. ARS2/MAGL signaling in glioblastoma stem cells promotes self-renewal and M2-like polarization of tumor-associated macrophages.
    Yin J; Kim SS; Choi E; Oh YT; Lin W; Kim TH; Sa JK; Hong JH; Park SH; Kwon HJ; Jin X; You Y; Kim JH; Kim H; Son J; Lee J; Nam DH; Choi KS; Shi B; Gwak HS; Yoo H; Iavarone A; Kim JH; Park JB
    Nat Commun; 2020 Jun; 11(1):2978. PubMed ID: 32532977
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Essential role of METTL3-mediated m
    Visvanathan A; Patil V; Arora A; Hegde AS; Arivazhagan A; Santosh V; Somasundaram K
    Oncogene; 2018 Jan; 37(4):522-533. PubMed ID: 28991227
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Metformin treatment reduces temozolomide resistance of glioblastoma cells.
    Yang SH; Li S; Lu G; Xue H; Kim DH; Zhu JJ; Liu Y
    Oncotarget; 2016 Nov; 7(48):78787-78803. PubMed ID: 27791206
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Downregulation of mitochondrial UQCRB inhibits cancer stem cell-like properties in glioblastoma.
    Jung N; Kwon HJ; Jung HJ
    Int J Oncol; 2018 Jan; 52(1):241-251. PubMed ID: 29115404
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Adenosine A3 receptor elicits chemoresistance mediated by multiple resistance-associated protein-1 in human glioblastoma stem-like cells.
    Torres A; Vargas Y; Uribe D; Jaramillo C; Gleisner A; Salazar-Onfray F; López MN; Melo R; Oyarzún C; San Martín R; Quezada C
    Oncotarget; 2016 Oct; 7(41):67373-67386. PubMed ID: 27634913
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate.
    Chen Q; Wu J; Ye Q; Ma F; Zhu Q; Wu Y; Shan C; Xie X; Li D; Zhan X; Li C; Li XF; Qin X; Zhao T; Wu H; Shi PY; Man J; Qin CF
    mBio; 2018 Sep; 9(5):. PubMed ID: 30228241
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Astrocytes enhance glioblastoma growth.
    Mega A; Hartmark Nilsen M; Leiss LW; Tobin NP; Miletic H; Sleire L; Strell C; Nelander S; Krona C; Hägerstrand D; Enger PØ; Nistér M; Östman A
    Glia; 2020 Feb; 68(2):316-327. PubMed ID: 31509308
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Targeting role of glioma stem cells for glioblastoma multiforme.
    Zhang X; Zhang W; Mao XG; Zhen HN; Cao WD; Hu SJ
    Curr Med Chem; 2013; 20(15):1974-84. PubMed ID: 23317162
    [TBL] [Abstract][Full Text] [Related]  

  • 76. mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance.
    Garros-Regulez L; Aldaz P; Arrizabalaga O; Moncho-Amor V; Carrasco-Garcia E; Manterola L; Moreno-Cugnon L; Barrena C; Villanua J; Ruiz I; Pollard S; Lovell-Badge R; Sampron N; Garcia I; Matheu A
    Expert Opin Ther Targets; 2016; 20(4):393-405. PubMed ID: 26878385
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Upregulation of miR-181a suppresses the formation of glioblastoma stem cells by targeting the Notch2 oncogene and correlates with good prognosis in patients with glioblastoma multiforme.
    Huang SX; Zhao ZY; Weng GH; He XY; Wu CJ; Fu CY; Sui ZY; Ma YS; Liu T
    Biochem Biophys Res Commun; 2017 May; 486(4):1129-1136. PubMed ID: 28389242
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Repurposing phenformin for the targeting of glioma stem cells and the treatment of glioblastoma.
    Jiang W; Finniss S; Cazacu S; Xiang C; Brodie Z; Mikkelsen T; Poisson L; Shackelford DB; Brodie C
    Oncotarget; 2016 Aug; 7(35):56456-56470. PubMed ID: 27486821
    [TBL] [Abstract][Full Text] [Related]  

  • 79. DJ-1 Contributes to Self-renewal of Stem Cells in the U87-MG Glioblastoma Cell Line.
    Toda Y; Yoshimura R; Itahara M; Imai Y; Yamada K; Uno T; Nakata S; Hosogi S; Takata K; Ashihara E
    Anticancer Res; 2019 Nov; 39(11):5983-5990. PubMed ID: 31704823
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Synergistic inhibition of tumor growth by combination treatment with drugs against different subpopulations of glioblastoma cells.
    Chang CH; Liu WT; Hung HC; Gean CY; Tsai HM; Su CL; Gean PW
    BMC Cancer; 2017 Dec; 17(1):905. PubMed ID: 29284440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.